Androgen receptor coactivators and prostate cancer

Advances in Experimental Medicine and Biology

Volumn 617, Issue , 2008, Pages 245-255

  Agoulnik, Irina U ^a   Weigel, Nancy L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; HISTONE ACETYLTRANSFERASE; NUCLEAR RECEPTOR COACTIVATOR 2; STEROID RECEPTOR COACTIVATOR 1; TRANSCRIPTION FACTOR;

CELL GROWTH; CONFERENCE PAPER; HORMONE ACTION; HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; MALE; METABOLISM; PROSTATE TUMOR; REVIEW;

HISTONE ACETYLTRANSFERASES; HUMANS; MALE; NUCLEAR RECEPTOR COACTIVATOR 2; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TRANSCRIPTION FACTORS;

EID: 46749097609     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-69080-3_23     Document Type: Conference Paper

References (45)

1. Arnold JT, Isaacs JT (2002) Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault. Endocr Relat Cancer 9:61-73.
2. Evans RM (1988) The steroid and thyroid hormone receptor superfamily. Science 240:889-895.
3. McEwan IJ (2004) Molecular mechanisms of androgen receptor-mediated gene regulation: structure-function analysis of the AF-1 domain. Endocr Relat Cancer 11:281-293.
4. Walcott JL, Merry DE (2002) Trinucleotide repeat disease. The androgen receptor in spinal and bulbar muscular atrophy. Vitam Horm 65:127-147.
5. Bevan CL, Hoare S, Claessens F, et al. (1999) The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1. Mol Cell Biol 19:8383-8392.
6. Simental JA, Sar M, Lane MV, et al. (1991) Transcriptional activation and nuclear targeting signals of the human androgen receptor. J Biol Chem 266:510-518.
7. He B, Kemppainen JA, Wilson EM (2000) FXXLF and WXXLF sequences mediate the NH2- terminal interaction with the ligand binding domain of the androgen receptor. J Biol Chem 275:22986-22994.
8. Sack JS, Kish KF, Wang C, et al. (2006) Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone. Proc Natl Acad Sci USA 98:4904-4909.
9. Beato M, Chalepakis G, Schauer M, et al. (1989) DNA regulatory elements for steroid hormones. J Steroid Biochem 32:737-747.
10. Migliaccio A, Castoria G, Di Domenico M, et al. (2000) Steroid-induced androgen receptor- oestradiol receptor β-Src complex triggers prostate cancer cell proliferation. EMBO J 19:5406-5417.
11. Agoulnik IU, Weigel NL (2006) Androgen receptor action in hormone-dependent and recurrent prostate cancer. J Cell Biochem Apr 17 [Epub ahead of print]:
12. Lamb DJ, Weigel NL, Marcelli M (2001) Androgen receptors and their biology. Vitam Horm 62:199-230.
13. Holzbeierlein J, Lal P, LaTulippe E, et al. (2004) Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance. Am J Pathol 164:217-227.
14. Balk SP (2002) Androgen receptor as a target in androgen-independent prostate cancer. Urology 60:132-139.
15. Li R, Wheeler T, Dai H, et al. (2004) High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate cancer patients treated with radical prostatectomy. Am J Surg Pathol 28:928-934.
16. Agoulnik IU, Vaid A, Bingman IWE, et al. (2005) Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression. Cancer Res 65:7959-7967.
17. Zegarra-Moro OL, Schmidt LJ, Huang H, et al. (2002) Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells. Cancer Res 62:1008-1013.
18. Culig Z, Hobisch A, Cronauer MV, et al. (1994) Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res 54:5474-5478.
19. Nazareth LV, Weigel NL (1996) Activation of the human androgen receptor through a protein kinase A signaling pathway. J Biol Chem 271:19900-19907.
20. Hobisch A, Eder IE, Putz T, et al. (1998) Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor. Cancer Res 58:4640-4645.
21. Titus MA, Schell MJ, Lih FB, et al. (2005) Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer. Clin Cancer Res 11:4653-4657.
22. Heinlein CA, Chang C (2002) Androgen receptor (AR) coregulators: an overview. Endocr Rev 23:175-200.
23. Yeh S-H, Miyamoto H, Shima H, et al. (1998) From estrogen to androgen receptor: a new pathway for sex hormones in prostate. Proc Natl Acad Sci USA 95:5527-5532.
24. Gregory CW, He B, Johnson RT, et al. (2001) A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res 61:4315-4319.
25. McKenna NJ, Xu J, Nawaz Z, et al. (1999) Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions. J Steroid Biochem Mol Biol 69:3-12.
26. Xu J, Qiu Y, DeMayo FJ, et al. (1998) Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 279:1922-1925.
27. Agoulnik IU, Vaid A, Nakka M, et al. (2006) Androgens modulate expression of TIF2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer. Cancer Res 66:10594-602.
28. Wang Q, Carroll JS, Brown M (2005) Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Mol Cell 19:631-642.
29. Gregory CW, Fei X, Ponguta LA, et al. (2004) Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer. J Biol Chem 279:7119-7130.
30. Zou JX, Zhong Z, Shi XB, et al. (2006) ACTR/AIB1/SRC-3 and androgen receptor control prostate cancer cell proliferation and tumor growth through direct control of cell cycle genes. Prostate [Epub ahead of print]:
31. Zhou G, Hashimoto Y, Kwak I, et al. (2003) Role of the steroid receptor coactivator SRC-3 in cell growth. Mol Cell Biol 23:7742-7755.
32. Zhou HJ, Yan J, Luo W, et al. (2005) SRC-3 is required for prostate cancer cell proliferation and survival. Cancer Res 65:7976-7983.
33. Majumder S, Liu Y, Ford OH, et al. (2006) Involvement of arginine methyltransferase CARM1 in androgen receptor function and prostate cancer cell viability. Prostate 66:1292-1301.
34. Link KA, Burd CJ, Williams E, et al. (2005) BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF. Mol Cell Biol 25:2200-2215.
35. Miyamoto H, Rahman M, Takatera H, et al. (2002) A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth. J Biol Chem 277:4609-4617.
36. Rahman MM, Miyamoto H, Lardy H, et al. (2003) Inactivation of androgen receptor coregulator ARA55 inhibits androgen receptor activity and agonist effect of antiandrogens in prostate cancer cells. Proc Natl Acad Sci USA 100:5124-5129.
37. Rahman MM, Miyamoto H, Takatera H, et al. (2003) Reducing the agonist activity of antiandrogens by a dominant-negative androgen receptor coregulator ARA70 in prostate cancer cells. J Biol Chem 278:19619-19626.
38. Wang L, Hsu CL, Chang C (2005) Androgen receptor corepressors: an overview. Prostate 63:117-130.
39. Agoulnik IU, Krause WC, Bingman WEI, et al. (2003) Repressors of androgen and progesterone receptor action. J Biol Chem 278:31136-31148.
40. Burd CJ, Petre CE, Morey LM, et al. (2006) Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation. Proc Natl Acad Sci USA 103:2190-2195.
41. Burd CJ, Petre CE, Moghadam H, et al. (2005) Cyclin D1 binding to the androgen receptor (AR) NH2-terminal domain inhibits activation function 2 association and reveals dual roles for AR corepression. Mol Endocrinol 19:607-620.
42. Martinez ED, Danielsen M (2002) Loss of androgen receptor transcriptional activity at the G(1)/S transition. J Biol Chem 277:29719-29729.
43. Karvonen U, Janne OA, Palvimo JJ (2006) Androgen receptor regulates nuclear trafficking and nuclear domain residency of corepressor HDAC7 in a ligand-dependent fashion. Exp Cell Res [Epub ahead of print]:
44. Chen G, Nomura M, Morinago H, et al. (2005) Modulation of androgen receptor transactivation by FoxH1. A newly identified androgen receptor corepressor. J Biol Chem 280:36355-36363.
45. Belandia B, Powell SM, Garcia-Pedrero JM, et al. (2005) Hey1, a mediator of notch signaling, is an androgen receptor corepressor. Mol Cell Biol 25:1425-1436.